Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave

Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)

(2020) Li Guo et al.   CLINICAL INFECTIOUS DISEASES

The paramount importance of serological surveys of SARS-CoV-2 infection and immunity

(2020) Jaap Goudsmit   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Strong associations and moderate predictive value of early symptoms for SARS-CoV-2 test positivity among healthcare workers, the Netherlands, March 2020

(2020) Alma Tostmann et al.   Eurosurveillance

Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020

(2020) Neeraj Sood et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

COVID-19 epidemic: Disease characteristics in children

(2020) Jiatong She et al.   JOURNAL OF MEDICAL VIROLOGY

What policy makers need to know about COVID-19 protective immunity

(2020) Daniel M Altmann et al.   LANCET

Connecting clusters of COVID-19: an epidemiological and serological investigation

(2020) Sarah Ee Fang Yong et al.   LANCET INFECTIOUS DISEASES

COVID-19: implications for immunosuppression in kidney disease and transplantation

(2020) Andreas Kronbichler et al.   Nature Reviews Nephrology

Spread of SARS-CoV-2 in the Icelandic Population

(2020) Daniel F. Gudbjartsson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China

(2020) Juanjuan Zhang et al.   SCIENCE

High COVID-19 Attack Rate Among Attendees at Events at a Church — Arkansas, March 2020

(2020) Allison James et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs

(2020) Zheng Xian Thng et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

SARS-CoV-2-specific antibody detection for sero-epidemiology: a multiplex analysis approach accounting for accurate seroprevalence

(2020) Gerco den Hartog et al.   JOURNAL OF INFECTIOUS DISEASES

Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta‐analysis

(2020) Jingjing He et al.   JOURNAL OF MEDICAL VIROLOGY

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

(2020) Silvia Stringhini et al.   LANCET

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

(2020) Marina Pollán et al.   LANCET

COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional study

(2020) Reina S Sikkema et al.   LANCET INFECTIOUS DISEASES

Estimates of the severity of coronavirus disease 2019: a model-based analysis

(2020) Robert Verity et al.   LANCET INFECTIOUS DISEASES

Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020

(2020) Fiona P. Havers et al.   JAMA Internal Medicine

Third national biobank for population-based seroprevalence studies in the Netherlands, including the Caribbean Netherlands

(2019) Janneke Doortje Maria Verberk et al.   BMC INFECTIOUS DISEASES

Fast stable restricted maximum likelihood and marginal likelihood estimation of semiparametric generalized linear models

(2010) Simon N. Wood   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY